DIETARY SUPPLEMENTS

Subscribe to DIETARY SUPPLEMENTS

FDA Releases Draft Guidance on NAC Enforcement

Posted on April 22, 2022

On April 21, 2022 FDA announced the issuance of draft guidance on FDA’s policy regarding dietary supplements containing N-acetyl cysteine (NAC). The guidance details the agency’s intent to exercise enforcement

…
Continue Reading FDA Releases Draft Guidance on NAC Enforcement

Challenge to Dietary Supplement Structure/Function Claims Preempted

Posted on April 5, 2022

On March 31, 2022, the U.S. District Court for the District of Massachusetts held that Plaintiffs’ claims— which alleged that the labels on three of Vitamin Shoppe, Inc.’s dietary supplements

…
Continue Reading Challenge to Dietary Supplement Structure/Function Claims Preempted

Permanent Injunction against Supplement Co.

Posted on March 10, 2022

On March 3, 2022, the United States Government, on behalf of FDA, filed a complaint against Salud Natural Entrepreneur, Inc. (“Salud”), as well as its owner, production manager, and quality

…
Continue Reading Permanent Injunction against Supplement Co.

FDA & FTC Issue Warning Letters to 10 Companies

Posted on September 14, 2021

On September 9, 2021, the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) jointly issued warning letters to 10 companies for illegally selling dietary supplements claiming to treat

…
Continue Reading FDA & FTC Issue Warning Letters to 10 Companies

Senators Unveil Draft Bill with Pathway for CBD

Posted on July 16, 2021

Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) unveiled a lengthy discussion draft titled the Cannabis Administration and Opportunity Act on July 14. The draft language is

…
Continue Reading Senators Unveil Draft Bill with Pathway for CBD

New Bipartisan Senate Bill Seeks Movement on CBD

Posted on May 21, 2021

U.S. Senators Ron Wyden (D-OR), Rand Paul (R-KY) and Jeff Merkley (D-OR) introduced S. 1698 on May 19, a bill to allow the use of cannabidiol (CBD) and other hemp

…
Continue Reading New Bipartisan Senate Bill Seeks Movement on CBD

Supplement Manufacturer Gets Permanent Injunction

Posted on March 5, 2021

Dietary supplement manufacturer Confidence USA Inc., located in Port Washington, New York, its president, and its general manager received a permanent injunction on March 4, 2021 from the U.S. District

…
Continue Reading Supplement Manufacturer Gets Permanent Injunction

FDA Warnings Against Supplements for Depression

Posted on February 22, 2021

FDA will evaluate claims and other information on a dietary supplement’s website to establish the product’s “intended use.” In general, a dietary supplement is allowed to make claims about having

…
Continue Reading FDA Warnings Against Supplements for Depression

New Citizens Petition Requests FDA Status for Hemp-Derived CBD in Dietary Supplements

Posted on June 22, 2020

We reported on a November 14, 2019 citizen petition submitted to FDA by the Consumer Healthcare Products Associated (CHPA) requesting that the agency issue regulations to establish a clear pathway

…
Continue Reading New Citizens Petition Requests FDA Status for Hemp-Derived CBD in Dietary Supplements

FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD

Posted on June 8, 2020

After public hearings and the first of two Congressionally mandated reports from FDA, discussed here, the market for FDA-regulated food and dietary supplement products that contain cannabidiol (CBD) continues

…
Continue Reading FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD